Nexgen Pharma Recalls L-Arginine Supplement Due to Subpotency
Nexgen Pharma is recalling a specific lot of L-Arginine L-Ornithine Alpha Lipoic Acid capsules because the Alpha Lipoic Acid ingredient is subpotent.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which indicates the product is unlikely to cause adverse health consequences. The issue is subpotency of an ingredient, which is a minor quality defect rather than a safety hazard like contamination or mislabeling of allergens.
Plain-English summary
Nexgen Pharma, Inc. is recalling a specific lot of Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid dietary supplements. The recall is due to the subpotency of the Alpha Lipoic Acid ingredient in the product.
The affected product is sold in 50 and 100-count bottles. The specific lot number is 412567. A total of 4,571 bottles were distributed to large and small retailers nationwide, as well as to two foreign locations in Canada and the Netherlands.
Consumers who have purchased this specific lot of the supplement should stop using it and contact the retailer where it was purchased for a refund or further instructions.
The recalled product
- Product
- Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution
- Manufacturer
- Nexgen Pharma, Inc.
- Category
- Food — Dietary Supplement
- Hazard
- Affected units
- 4,571
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot number 412567.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Nexgen Pharma, Inc.
See all →- Severe
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22